跳至主要内容
临床试验/NCT07718269
NCT07718269已完成4 期

Microneedling With 5-Fluorouracil Versus Intralesional 5-Fluorouracil or Corticosteroids for Hypertrophic Scars and Keloids

Alexandria University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年1月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
the efficacy

研究概览

简要总结

The goal of this clinical trial is to learn about the efficacy and safety of microneedling-assisted 5-fluorouracil delivery in comparison with intralesional 5-fluorouracil, intralesional corticosteroid, and microneedling with saline for the treatment of pathological scars.

详细描述

Hypertrophic scars and keloids are dermal fibroproliferative disorders unique to humans. They are common and usually occur following burns, trauma, inflammation, or surgery, but sometimes occur spontaneously. Despite an array of therapeutic approaches for scar therapy such as surgical excision, occlusive dressings, topical and intralesional corticosteroids, interferon, cryosurgery, radiation, pressure therapy, laser therapy, retinoic acid, and silicone gel sheeting, no single method provides complete benefit. For this reason, the medical care of HTSs and keloids remains clinically challenging. The study was conducted on 60 patients complaining of HTSs & keloids.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The outcomes assessor will be blinded to the treatment allocation to reduce assessment bias during evaluation of scar improvement.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed with HTSs or keloids

排除标准

  • pregnant or lactating females, immunocompromised patients

研究组 & 干预措施

Microneedling with 5-Fluorouracil

Active Comparator

Intervention Name: Microneedling With 5 Fluorouracil Intervention Type: Procedure

干预措施: Microneedling with 5-Fluorouracil (Procedure)

Intralesional 5-Fluorouracil

Active Comparator

Intervention name: Intralesional 5-Fluorouracil Intervention Type: drug

干预措施: Intralesional 5-fluorouracil (Drug)

Microneedling with normal saline

Placebo Comparator

Intervention name: Microneedling with normal saline Intervention type: Procedure

干预措施: Microneedling With saline (Procedure)

结局指标

主要结局

the efficacy

时间窗: 3 weeks

to detect the Change in scar severity assessed by the Vancouver Scar Scale

Vancouver Scar Scale

时间窗: 3 weeks

To detect the Change in scar severity assessed by the Vancouver Scar Scale based on four scar characteristics (vascularity 0-3, pliability 0-5, height 0-3, pigmentation 0-2) with the minimum total score 0 (normal) and the maximum total score 13 (most severe scar). Higher scores after treatment mean worse outcome.

ImageJ Analysis

时间窗: 3 weeks

To objectively assess scar surface area. To quantify treatment effect, the percentage of change in scar area was calculated for each patient using the formula: ■("Percentage of change=" ("Post treatment area - Baseline area" /"Baseline area" )"×100" ), Higher scores mean worse outcomes.

次要结局

  • Patient's satisfaction score(3 weeks)
  • visual analogue scale(3 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shimaa Ismail Abdelhamid

Associate Professor of Dermatology

Alexandria University

研究点 (1)

Loading locations...

相似试验

Microneedling vs. 5-Fluorouracil or Steroid... | 临床试验